Innosuisse - Swiss Innovation Agency
Innosuisse - Swiss Innovation Agency
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fatigue Investigation Using Digital Outcomes | CNS demyelinating autoimmune disease, COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Fatigue, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, long COVID-19, lung disorder, multiple sclerosis, nervous system disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-08-24 | NCT07783074 | |
| SwissNeuroRehab - HDHI | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-03-10 | NCT07427511 | |
| DreaMS - Validation Study 1 | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Not stated | 2026-03-10 | NCT05009160 |